Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zotrip: ZP-Zolmitriptan Microneedle System for Acute Migraine
NCT02745392Phase 3Completed
- Sponsor
- Zosano Pharma
- Start
- Jun 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ZP-Triptan in migraine, sponsored by Zosano Pharma. Started Jun 2016; status: completed.
02
Drugs
ZP-Triptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02745392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745392.